Letter by Hess et al Regarding Article, “How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
In a Clinician Update, Dr Lip seems to recommend oral anticoagulation for all patients with device-detected atrial high-rate episodes (AHREs) and a CHA2DS2-VASc score of at least 1.1 Unfortunately, this recommendation is not evidence based. Although the TRENDS study (The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk)2 and ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and Atrial Fibrillation Reduction Atrial Pacing Trial) …